Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease
Honghua Zhang, Yuying Wang, Yuqing Wang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 240, pp. 114606-114606
Closed Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

NMDA Receptor Antagonists: Emerging Insights into Molecular Mechanisms and Clinical Applications in Neurological Disorders
Ayodeji O. Egunlusi, Jacques Joubert
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 639-639
Open Access | Times Cited: 11
RIPK1 inhibitors: A key to unlocking the potential of necroptosis in drug development
Yinliang Bai, Yujun Qiao, Mingming Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116123-116123
Closed Access | Times Cited: 9
New insights into butyrylcholinesterase: Pharmaceutical applications, selective inhibitors and multitarget-directed ligands
Tian‐Yu Sun, Tengfei Zhen, Chrisanta Hamis Harakandi, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116569-116569
Closed Access | Times Cited: 8
Lipoic acid scaffold applications in the design of multitarget-directed ligands against Alzheimer’s disease
Mohammad Amin Manavi, Mona Nourhashemi, Saeed Emami, et al.
Bioorganic Chemistry (2025), pp. 108241-108241
Closed Access
Design, synthesis and evaluation of quinoline- O -carbamate derivatives as multifunctional agents for the treatment of Alzheimer’s disease
Hongsong Chen, Jing Mi, Sen Li, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 17
Effect and mechanism of acupuncture on Alzheimer’s disease: A review
Liu Wu, Yuting Dong, Chengcheng Zhu, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 17
Development of the “hidden” multi-target-directed ligands by AChE/BuChE for the treatment of Alzheimer's disease
Rui Chen, Xinjuan Li, Hongsong Chen, et al.
European Journal of Medicinal Chemistry (2023) Vol. 251, pp. 115253-115253
Closed Access | Times Cited: 14
Sweroside: An iridoid glycoside of potential neuroprotective, antidiabetic, and antioxidant activities supported by molecular docking
Gökhan Zengin, Mohamed A. El Raey, Walaa A. El‐Kashak, et al.
Amino Acids (2023) Vol. 55, Iss. 12, pp. 1765-1774
Closed Access | Times Cited: 14
Pristine 2-chloroquinoline-based-thiosemicarbazones as multitarget agents against alzheimer's disease: In vitro and in silico studies of monoamine oxidase (MAO) and cholinesterase (ChE) inhibitors
Saquib Jalil, Rabia Basri, Mubashir Aziz, et al.
Journal of Molecular Structure (2024) Vol. 1306, pp. 137841-137841
Closed Access | Times Cited: 5
Design, Synthesis and Anticholinesterase Activity of Coumarin‐1,3,5‐triazine Derivatives
Xiaoqing Zhang, Jing Wang, Jing‐Pei Zou, et al.
ChemistrySelect (2024) Vol. 9, Iss. 3
Closed Access | Times Cited: 4
Effect of pesticides on phosphorylation of tau protein, and its influence on Alzheimer’s disease
Erandis D. Torres-Sánchez, Genaro Gabriel Ortíz, Emmanuel Reyes-Uribe, et al.
World Journal of Clinical Cases (2023) Vol. 11, Iss. 24, pp. 5628-5642
Open Access | Times Cited: 12
Carbamate as a potential anti‐Alzheimer's pharmacophore: A review
Yash Pal Singh, Navneet Kumar, Brijesh Singh Chauhan, et al.
Drug Development Research (2023) Vol. 84, Iss. 8, pp. 1624-1651
Closed Access | Times Cited: 12
Design of a new potent Alzheimer's disease inhibitor based on QSAR, molecular docking and molecular dynamics investigations
Meriem Khedraoui, Hassan Nour, Imane Yamari, et al.
Chemical Physics Impact (2023) Vol. 7, pp. 100361-100361
Open Access | Times Cited: 12
Deciphering Neuroprotective Effect of Rosmarinus officinalis L. (syn. Salvia rosmarinus Spenn.) through Preclinical and Clinical Studies
Ibukun O. Oresanya, İlkay Erdoğan Orhan
Current Drug Targets (2024) Vol. 25, Iss. 5, pp. 330-352
Closed Access | Times Cited: 3
Novel anti-neuroinflammatory pyranone-carbamate derivatives as selective butyrylcholinesterase inhibitors for treating Alzheimer’s disease
Chuanyu Yu, Xueyan Liu, Bingxiang Ma, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 3
Polymer–drug conjugates as nano-sized multi-targeting systems for the treatment of Alzheimer's disease
Nuruddin Mahadik, Gemma A. Barron, Paul Kong Thoo Lin, et al.
RSC Pharmaceutics (2024) Vol. 1, Iss. 2, pp. 161-181
Open Access | Times Cited: 3
Design and synthesis of phenoxy methyl‐oxadiazole compounds against Alzheimer's disease
Asaf Evrim Evren, Demokrat Nuha, Begüm Nurpelin Sağlık, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 8
Closed Access | Times Cited: 3
Recent development and strategies towards target interactions: Synthesis, characterization and in silico analysis of benzimidazole based thiadiazole as potential anti-Alzheimer agents
Shoaib Khan, Rafaqat Hussain, Tayyiaba Iqbal, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 726, pp. 150201-150201
Closed Access | Times Cited: 2
Recent advance on pleiotropic cholinesterase inhibitors bearing amyloid modulation efficacy
Honghua Zhang, Yan Peng, Linsheng Zhuo, et al.
European Journal of Medicinal Chemistry (2022) Vol. 242, pp. 114695-114695
Closed Access | Times Cited: 14
Discovery of novel hybrids containing clioquinol−1-benzyl-1,2,3,6-tetrahydropyridine as multi-target-directed ligands (MTDLs) against Alzheimer's disease
Xinnan Li, Tiantian Li, Pengfei Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114841-114841
Open Access | Times Cited: 14
Constructing brain functional network by Adversarial Temporal-Spatial Aligned Transformer for early AD analysis
Qiankun Zuo, Libin Lu, Lin Wang, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 12
Novel Thiosemicarbazone Quantum Dots in the Treatment of Alzheimer’s Disease Combining In Silico Models Using Fingerprints and Physicochemical Descriptors
Nguyen Minh Quang, Trần Thái Hoà, Hoa Le Thi, et al.
ACS Omega (2023) Vol. 8, Iss. 12, pp. 11076-11099
Open Access | Times Cited: 5
Development of novel salicylic acid–donepezil–rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer’s disease
Yi Zhou, Ying He, Teng Xue, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 5
Discovery of blood-brain barrier permeable and orally bioavailable caffeine-based amide derivatives as acetylcholinesterase inhibitors
Mohit Sharma, Ankita Sharma, Shikha Thakur, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106719-106719
Closed Access | Times Cited: 5
Human blood markers of cholinergic neurotoxicity and neuropathy: A useful guide for laboratory applications
Guilherme Luz Emerick, Valfran da Silva Lima, B. Costa, et al.
NeuroToxicology (2024) Vol. 101, pp. 16-25
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top